These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Management of infections due to resistant enterococci: a review of therapeutic options. Landman D; Quale JM J Antimicrob Chemother; 1997 Aug; 40(2):161-70. PubMed ID: 9301980 [TBL] [Abstract][Full Text] [Related]
7. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine]. Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology and control of multiresistant enterococci. Leclercq R Drugs; 1996; 52 Suppl 2():47-9. PubMed ID: 8869836 [No Abstract] [Full Text] [Related]
11. Prevalence of high level aminoglycoside and vancomycin resistance among enterococci in Turkey. Cirak MY; Sultan N Acta Microbiol Pol; 1998; 47(3):267-73. PubMed ID: 9990710 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance of enterococci in Turkey. Kaçmaz B; Aksoy A Int J Antimicrob Agents; 2005 Jun; 25(6):535-8. PubMed ID: 15908184 [TBL] [Abstract][Full Text] [Related]
16. [Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents]. Guirguitzova B; Chankova D; Zozikov B; Minkov N Ann Urol (Paris); 1998; 32(1):15-9. PubMed ID: 9559070 [TBL] [Abstract][Full Text] [Related]
17. [Enterococcus: phenotype and genotype resistance and epidemiology in Spain]. Cercenado E Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():59-65. PubMed ID: 22305671 [TBL] [Abstract][Full Text] [Related]
18. [Enterococci resistant to glycopeptides]. Cattoir V; Leclercq R Med Sci (Paris); 2010 Nov; 26(11):936-42. PubMed ID: 21106175 [TBL] [Abstract][Full Text] [Related]
19. Penicillin resistance and aminoglycoside-penicillin synergy in enterococci. Lopardo HA; Venuta ME; Rubeglio EA Chemotherapy; 1995; 41(3):165-71. PubMed ID: 7656661 [TBL] [Abstract][Full Text] [Related]